Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cash-Poor Biotechs Should Get U.S. Money to Develop Medicine, Collins Says
Bloomberg
Thursday, July 8, 2010 - 8:56am
tags:
biotechs
Novartis Challenges USPTO Patent Extension Policy
Forbes
Thursday, July 8, 2010 - 8:54am
tags:
Novartis, patents, USPTO, Wyeth, vaccines
Eisai rethinks its game to beat China rivals
FT.com
Wednesday, July 7, 2010 - 6:56pm
tags:
China, Eisai, Astellas
Early-stage ALS stem cell study clears initial safety hurdle
Fierce Biotech
Wednesday, July 7, 2010 - 6:54pm
tags:
ALS, stem cells, Lou Gehrig's disease
Alcon Aims, Fires, Bags LenSx for $361.5 Million
Forbes
Wednesday, July 7, 2010 - 6:52pm
tags:
Alcon, LenSx, M&A
Teva dissolves unit in management restructuring
Fierce Pharma
Wednesday, July 7, 2010 - 12:18pm
tags:
Teva Pharmaceuticals, Barr Laboratories, restructuring
XenoPort shares drop 26% after failed trial
Marketwatch
Wednesday, July 7, 2010 - 12:16pm
tags:
XenoPort, GSK, migraines
Bristol-Myers' Orencia gets expanded use in Europe
Yahoo/AP
Wednesday, July 7, 2010 - 12:15pm
tags:
Bristol-Myers Squibb, Orencia, Europe, rheumatoid arthritis
FDA Nod for Shire Drug
Yahoo/Zacks.com
Wednesday, July 7, 2010 - 12:13pm
tags:
FDA, Shire, Daytrana, JNJ, Novartis, ADHD
Big Pharma's Mantra: Fail Early, Fail Fast
Seeking Alpha
Wednesday, July 7, 2010 - 12:12pm
tags:
Big Pharma, GSK, Pfizer, clinical trials
Top 10 Pharma CEO salaries of 2009
Fierce Pharma
Wednesday, July 7, 2010 - 9:55am
tags:
Pharma CEOs, executive pay
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wednesday, July 7, 2010 - 9:36am
tags:
Vivus, Qnexa, Myriad, Genomic Health, NicOx, naproxcinod, Savient, Krystexxa, Novartis, Gilenia, Seattle Genetics, Gilead Sciences, Chelsea Therapeutics, Eisai
A Medical Journal And A ‘Slick’ Paper About Niaspan
Pharmalot
Wednesday, July 7, 2010 - 9:29am
tags:
Niaspan, Abbott Laboratories
XenoPort, Glaxo Migrane Drug Fails To Outperform Placebo
WSJ Online
Wednesday, July 7, 2010 - 9:27am
tags:
XenoPort, GSK, migraines, clinical trials
Dendreon and Provenge: What if We Lived in England?
Seeking Alpha
Wednesday, July 7, 2010 - 9:05am
tags:
Dendreon, Provenge, England, vaccines, prostate cancer
Roche submits breast cancer drug for FDA approval
Reuters
Wednesday, July 7, 2010 - 8:59am
tags:
Roche, breast cancer, FDA, Trastuzumab-Dm1
Aspen Pharmacare Lowers its Sigma Takeover Offer Proposal by 8.3 Percent
Bloomberg
Wednesday, July 7, 2010 - 8:57am
tags:
Aspen, M&A, Sigma, Africa
Sex Diseases Tripled in Men 40 or Older Taking Viagra, Cialis, Study Says
Bloomberg
Wednesday, July 7, 2010 - 8:56am
tags:
Cialis, Viagra, Eli Lilly, Pfizer, erectile dysfunction
Dynavax gets grant for work on new HPV vaccine
Yahoo/AP
Wednesday, July 7, 2010 - 8:39am
tags:
HPV, Dynavax, vaccines, grants
How to Hitch Ride on Health-Care Investing
Yahoo/TheStreet.com
Wednesday, July 7, 2010 - 8:37am
tags:
GSK, JNJ, Novartis, Pfizer, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.